6,7-Dihydroxyflavone Dramatically Intensifies the Susceptibility of Methicillin-Resistant or -Sensitive Staphylococcus aureus to β-Lactams

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 4, 2004, Pages 1357-1360

  Sato, Youichi ^a   Shibata, Hirofumi ^a   Arakaki, Naokatu ^a   Higuti, Tomihiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIHYDROXYFLAVONE; BETA LACTAM ANTIBIOTIC; CEFAPIRIN; CEFOTAXIME; ERYTHROMYCIN; FLAVONE DERIVATIVE; KANAMYCIN; METICILLIN; OFLOXACIN; OXACILLIN; PANIPENEM; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BETA-LACTAMS; COLONY COUNT, MICROBIAL; DRUG SYNERGISM; FLAVONOIDS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 1642420282     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.4.1357-1360.2004     Document Type: Article

References (19)

1. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1997. Activities of levofloxacin, ofloxacin, and ciprofloxacin alone and in combination with amikacin against acinetobacters, as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41:1073-1076.
2. Cui, L., X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M. Mamizuka, C. G. Gemmell, M. N. Kim, M. C. Ploy, N. E. Solh, V. Ferraz, and K. Hiramatsu. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41:5-14.
3. Giesbrecht, P., T. Kersten, H. Maidhof, and J. Wecke. 1998. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62:1371-1414.
4. Guz, N. R., F. R. Stermitz, J. B. Johnson, T. D. Beeson, S. Willen, J. F. Hsiang, and K. Lewis. 2001. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. J. Med. Chem. 44:261-268.
5. Higuchi, T., Y. Sato, and S. Murasugi. September 2001. Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA. U.S. patent 6,294,526 B1.
6. Higuti, T., T. Negama, M. Takigawa, J. Uchida, T. Yamane, T. Asai, I. Tani, K. Oeda, M. Shimizu, K. Nakamura, and H. Ohkawa. 1988. A hydrophobic protein, chargerin II, purified from rat liver mitochondria is encoded in the unidentified reading frame A6L of mitochondrial DNA. J. Biol. Chem. 263:6772-6776.
7. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
8. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
9. Levy, S. B. 1998. The challenge of antibiotic resistance. Sci. Am. 278:46-53.
10. Nijveldt, R. J., E. Nood, D. E. Hoorn, P. G. Boelens, K. Norren, and P. A. Leeuwen. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74:418-425.
11. Oliver, B., B. Wolfgang, and P. Gerhard. 1997. Regulation of β-lactamase synthesis as a novel site of action for suppression of methicillin resistance in Staphylococcus aureus. Zentbl. Bakteriol. 285:413-430.
12. Putman, M., H. W. van Veen, and W. N. Konings. 2000. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:672-693.
13. Sato, Y., S. Suzaki, T. Nishikawa, M. Kihara, H. Shibata, and T. Higuti. 2000. Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 72:483-488.
14. Sekiguchi, K., M. Saito, and R. Yajima. 1995. Detection of methicillin-resistant Staphylococcus aureus (MRSA) with antibodies against synthetic peptides derived from penicillin-binding protein 2′. Microbiol. Immunol. 39:545-550.
15. Shibata, H., C. Shirakata, H. Kawasaki, Y. Sato, T. Kuwahara, Y. Ohnishi, N. Arakaki, and T. Higuti. 2003. Flavone markedly affects phenotypic expression of β-lactam resistance in methicillin-resistant Staphylococcus aureus strains isolated clinically. Biol. Pharm. Bull. 26:1478-1483.
16. Tomasz, A. 2000. The staphylococcal cell wall, p. 351-360. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. American Society for Microbiology, Washington, D.C.
17. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
18. Weigel, L. M. 2002. High-level vancomycin resistance in a clinical isolate of Staphylococcus aureus, p. 16. In Proceedings of the 10th International Symposium on Staphylococci and Staphylococcal Infections.
19. Wootton, M., R. A. Howe, T. R. Walsh, P. M. Bennett, and A. P. MacGowan. 2002. In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and hetero VRSA (hVRSA). J. Antimicrob. Chemother. 50:755-766.